MétaCan
Menu
Back to cohort
Record W2131272189 · doi:10.1128/cvi.13.4.444-451.2006

Laboratory Diagnostic Systems for Ebola and Marburg Hemorrhagic Fevers Developed with Recombinant Proteins

2006· review· en· W2131272189 on OpenAlexaboutno aff
Masayuki Saijo, Masahiro Niikura, Tetsuro Ikegami, Ichiro Kurane, Takeshi Kurata, Shigeru Morikawa

Bibliographic record

VenueClinical and Vaccine Immunology · 2006
Typereview
Languageen
FieldMedicine
TopicViral Infections and Outbreaks Research
Canadian institutionsnot available
Fundersnot available
KeywordsMarburg virusFiloviridaeEbola virusVirologyEbolavirusRecombinant DNAMedicineImmunologyBiologyVirusViral disease

Abstract

fetched live from OpenAlex

Ebola virus and Marburg virus (EBOV and MARV, respectively) of the family Filoviridae cause hemorrhagic fever with high mortality rates, sometimes reaching 50 to 90% of infected individuals, in humans and nonhuman primates (10,16,47).EBOV consists of four species, Zaire EBOV, Sudan EBOV, Ivory Coast EBOV, and Reston EBOV, which were first isolated in the Democratic Republic of Congo, Sudan, Ivory Coast, and the Philippines, respectively (47).MARV consists of one species, Lake Victoria MARV.Public health concerns about filovirus infection have increased in recent years.First, there have recently been large outbreaks of hemorrhagic fevers caused by EBOV (Ebola hemorrhagic fever [EHF]) and MARV (Marburg hemorrhagic fever [MHF]) in Africa; EHF outbreaks occurred in the Democratic Republic of Congo and Uganda in 1995 and 2000, respectively, and MHF outbreaks occurred in the Democratic Republic of Congo in 1998 -1999 and in Angola in 2004 -2005 (1, 7, 27, 56, 58-60) (1, 7, 27, 56, 58-60).Second, there is a possibility that filoviruses may be used as bioweapons.In this regard, filoviruses are classified as category A warfare agents by the U.S. government and are considered to pose a great risk to international security, along with anthrax, botulism, tularemia, and smallpox (2).As the magnitude of international trade and travel is continuously increasing, there is a significant risk that the hemorrhagic fever viruses could be introduced to virus-free countries from areas where they are endemic.Therefore, the development of laboratory diagnostic systems for EHF and MHF is an important subject even in countries without viral hemorrhagic fevers.Manipulation of infectious hemorrhagic fever viruses such as EBOV, MARV, Crimean-Congo hemorrhagic fever virus, and Lassa virus requires a biosafety level 4 (BSL-4) laboratory, which is designed for work with dangerous and exotic agents that pose a high risk of laboratory infection and life-threatening disease.However, BSL-4 laboratories are only available in a limited group of countries, such as the United States, Canada, France, the United Kingdom, Germany, South Africa, Sweden, and Russia.To get around the need for BSL-4 laboratories, recombinant viral antigens are used for immunodiagnostics.The recombi-nant proteins of these viruses have been expressed, and serological diagnostic methods have been developed using the recombinant proteins.Antigen detection systems have also been developed using recombinant antigens.In this article, recent progress in the development of diagnostic methods for EHF and MHF is reviewed.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.979
Threshold uncertainty score0.997

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0020.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.079
GPT teacher head0.410
Teacher spread0.331 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations75
Published2006
Admission routes1
Has abstractyes

Explore more

Same venueClinical and Vaccine ImmunologySame topicViral Infections and Outbreaks ResearchFrench-language works237,207